Discussion Forums > Working Towards a Cure

Bluebird Bio Releases Data on Current Gene Therapy Trials

<< < (10/39) > >>

JV:
As Sharmin said... Fertility issues and post transplant medication/care.

Thanks Andy

Bostonian_04:
Andy,
Thanks for talking to Bluebird....Few questions in my mind is...

1. which hospitals in US are they partnering with for these trials.
2. what are their main challenges and setbacks so far....not asking about financials.. from patient safety.
3. when can we expect it to be a mainstream cure...covered by insurance.

there are so many questions...but answering these few wiil do :) I am sure other members and you have additional questions.

catchR:
Andy,
can we also understand the reason for variance in hb (beta-T87Q) patient to patient post administration of Lenti-globin? How they are trying to achieve a similar hb increase for different patients.
And obviously safety concerns is another must ask.

thanks Andy!

Sharmin:
I'm not sure if this is valid question - but I wonder about the interim period - while waiting for the new treated marrow to engraft, how the patient is supported.  I am guessing transfusions of red bloods cells and ivig?

catchR:
I don't know if I put by question currently: my question was why there is difference in hb increase post gene drug administration between patients

is it because of varying amounts of vector being administered??

Navigation

[0] Message Index

[#] Next page

[*] Previous page